Aurora Innovation, BYD, and Tempus AI are just three of Lingotto Innovation’s holdings with explosive growth potential.

AstraZeneca’s AI algorithms, developed based on biomarkers and diagnosis data points, have shown promise in broadening the ...

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...